Jump-starting cheaper cancer vaccines

September 27, 2012

Dendritic cells (DCs) – workhorses of the immune system – derived from human embryonic stem cells (hESCs) may provide an economical way of generating off-the-shelf therapeutic vaccines against cancers, according to research led by Jieming Zeng and Shu Wang from the A*STAR institute of Bioengineering and Nanotechnology, Singapore. (Medical Xpress)